Florida TSRI campus receives $6 million for alternative HIV/AIDS vaccine
This revolutionary vaccine has shown promising potential in studies involving animal models.
The researchers use a novel approach in fighting HIV. The vaccine is designed to coerce the muscle cells into manufacturing inhibitor proteins, which can then block important sites located on the surface of the virus. The virus usually uses the proteins to attach and invade the human immune cells, so manipulating these proteins will trick the virus into believe that it has bound itself to a human cells.
When the virus is not able to attach to human cells, it is not able to reproduce itself, so the virus will remain impotent within the bloodstream.
The Gates Foundation has awarded the scientists the first grant that will be used solely to support the research. This is the first time that the Gates Foundation has granted funds to a Scrips Florida scientist.
"I'm grateful to the Gates Foundation for its strong support of our research and for its continued commitment to eradicating HIV/AIDS throughout the world," Michael Farzan, TSRI professor and leader of the research, said.